Clinical Trials
Sanofi and Regeneron Report Positive Preliminary Phase 2 Program...
Sanofi and Regeneron Pharmaceuticals, Inc. announced positive preliminary results from the Phase 2 study program in which patients with elevated low-density lipoprotein cholesterol (LDL-C) were...
Clinical Trials
TxCell presents final positive results of the phase I/II...
TxCell SA, a biotechnology company developing Treg cell-based immunotherapies for the treatment of severe chronic inflammatory diseases with high unmet medical needs, announces today the...
Clinical Trials
First results from ongoing Phase III trial show malaria...
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria...
Clinical Trials
AstraZeneca and Forest Laboratories to initiate phase III clinical...
AstraZeneca and Forest Laboratories, Inc. announced today that ceftazidime/avibactam (CAZ-AVI) will enter phase III trials to investigate efficacy in treating hospitalised patients with serious Gram-negative...
Clinical Trials
Acetylon Pharma starts treating patients in Phase 1-2a multiple...
Acetylon Pharmaceuticals has started treating patients in a three-part Phase 1-2a trial to evaluate ACY-1215 in adult patients suffering from relapsed and relapsed/refractory multiple...
Clinical Trials
Neurocrine starts tardive dyskinesia drug Phase II trial
US based Neurocrine Biosciences has started a second double-blind, placebo controlled, randomized cross-over Phase II trial to evaluate NBI- 98854. ...
Clinical Trials
Bionor Pharma to initiate HIV Vacc-4x combination trial
Bionor Pharma is set to initiate a double blinded, randomized and placebo-controlled trial to evaluate HIV-vaccine candidate Vacc-4x in combination with Revlimid.Revlimid is indicated as...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.